MARK2 and breast cancer: SNRK (SNF1-related kinase), a serine/threonine kinase first identified from the earliest population of CD34+ hematopoietic progenitors that form in the aorta of the human embryo, has been scarcely reported regarding its role in breast cancer and TANs 38.